Assess the Value of Specialty Drugs with Robert Popovian, Senior Director, Pfizer
Managing costs and determining the value of specialty drugs is key in understanding if the specialty model is sustainable. Hear from Robert Popovian, Senior Director, US Government Relations, Pfizer at IIR’s all-new Specialty Pharmacy Collaboration Summit, as he addresses the optimal methodologies to assess the value and cost proposition of specialty drugs in the evolving payment policy environment.
Learn How To:
• Define quality measures for specialty medicines
• Ensure global payment models which encapsulate all costs and outcomes including those for pharmaceuticals
• Develop measures of quality and value that are relevant to patients
Download the brochure for the full agenda and speaker details.
Don’t miss out! This Friday, June 27th is your last chance to save up to $600! Plus take an EXTRA $100 off when you use the code XP1968BLOG. Click here to register or call 888-670-8200 to register.